NCT07125872Phase 2Recruiting

Study of Relapsed/ Refractory B-cell Non- Hodgkin Lymphoma

Study sponsor: ImmunityBio, Inc. · IBRX

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2027-05-25Estimated
Enrollment · participants20Estimated
Source updated2026-05-04Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Recruitment status changed

− Before

Not yet recruiting

+ After

Recruiting

Check registry source